tradingkey.logo
tradingkey.logo
検索

Merck & Co Inc

MRK
ウォッチリストに追加
120.360USD
+0.760+0.64%
取引時間 ET15分遅れの株価
299.38B時価総額
33.74直近12ヶ月PER

詳細情報 Merck & Co Inc 企業名

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Merck & Co Incの企業情報

企業コードMRK
会社名Merck & Co Inc
上場日Feb 06, 2077
最高経営責任者「CEO」Davis (Robert M)
従業員数75000
証券種類Ordinary Share
決算期末Feb 06
本社所在地126 East Lincoln Avenue
都市RAHWAY
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号07065
電話番号19087404000
ウェブサイトhttps://www.merck.com/
企業コードMRK
上場日Feb 06, 2077
最高経営責任者「CEO」Davis (Robert M)

Merck & Co Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
70.41K
+2.13%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
56.20K
+1.78%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Mr. Inge G. Thulin
Mr. Inge G. Thulin
Independent Director
Independent Director
2.93K
--
Ms. Pamela J. Craig
Ms. Pamela J. Craig
Independent Director
Independent Director
1.72K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
70.41K
+2.13%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
56.20K
+1.78%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%

よくある質問

Merck & Co Incの上位5名の株主は誰ですか?

Merck & Co Incの上位5名の株主は以下のとおりです。Mr. Robert M. (Rob) Davis

Merck & Co Inc(MRK)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Merck & Co Incの株式を保有している機関は5687社あり、保有株式の総市場価値は約2.01Bで、全体の81.41%を占めています。2025Q4と比較して、機関の持ち株は-10595247.00増加しています。

Merck & Co Incの最大の収益源は何ですか?

2026Q1において、Oncology-Keytruda部門がMerck & Co Incにとって最大の収益を生み出しており、その金額は31.64Bで、全収益の48.67%を占めています。
KeyAI